Lsp Generation Iv
NY · 3 filings, 2025
Lobbying spend · 2025
$270K
to shape legislation
About the organization
Atypical antipsychotics (AAP), also known as second generation antipsychotics (SGAs) and serotonin–dopamine antagonists (SDAs), are a group of antipsychotic drugs (also generally known as tranquilizers and neuroleptics) used to treat psychiatric conditions. Largely introduced after the 1970s, most are approved for schizophrenia, with some having received additional approval for bipolar disorder, irritability in autism, and as an adjunct in major depressive disorder. via Wikipedia ↗
1Lobbies on
Its filings list: Energy/Nuclear · Environment/Superfund · Natural Resources · Real Estate/Land Use/Conservation · Trade (domestic/foreign)
2Through these firms · 1
MINDSET ADVOCACY, LLC
3Bills moving in its lanes
No bill names this company outright; these are recent bills in the sectors it lobbies.